BCL2L1 and cancer: [1, 2] As the major regulators of the intrinsic mitochondrial pathway of apoptosis, the pro-survival BCL-2 family proteins (BCL-2, BCL-XL, MCL-1, and BCL2A1) are attractive targets for novel cancer therapeutics.